AMLEXANOX Drug Patent Profile
Which patents cover Amlexanox, and what generic alternatives are available?
Amlexanox is a drug marketed by Uluru and is included in one NDA.
The generic ingredient in AMLEXANOX is amlexanox. There is one drug master file entry for this compound. Additional details are available on the amlexanox profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMLEXANOX?
- What are the global sales for AMLEXANOX?
- What is Average Wholesale Price for AMLEXANOX?
Summary for AMLEXANOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,932 |
| DailyMed Link: | AMLEXANOX at DailyMed |
Recent Clinical Trials for AMLEXANOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Michigan | Phase 2 |
| Access Pharmaceuticals, Inc. | Phase 2 |
| Advanced Clinical Research Services, LLC | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for AMLEXANOX
US Patents and Regulatory Information for AMLEXANOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uluru | AMLEXANOX | amlexanox | PATCH;TOPICAL | 021727-001 | Sep 29, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
